A growing number of individuals are seeking compensation claims against manufacturers of the heartburn medication Zantac. Complaints against the drug center around possible links to certaincancers, leading to a flood of legal actions. The US government has also phased out the sale of Zantac, further fueling concerns about its safety. Legal experts